Simple view
Full metadata view
Authors
Statistics
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib
Journal
Leukemia
200
Author
Machova Polakova Katerina
Albeer Ali
Polivkova Vaclava
Krutska Monika
Vlcanova Katerina
Curik Nikola
Fabarius Alice
Klamova Hana
Spiess Birgit
Waller Cornelius F.
Brümmendorf Tim H.
Dengler Jolanta
Kunzmann Volker
Burchert Andreas
Belohlavkova Petra
Mustjoki Satu
Faber Edgar
Mayer Jiri
Zackova Daniela
Panayiotidis Panayiotis
Richter Johan
Hjorth-Hansen Henrik
Kamińska Magdalena
Płonka-Stępień Magdalena
Szczepanek Elżbieta
Szarejko Monika
Bober Grażyna
Hus Iwona
Grzybowska-Izydorczyk Olga
Wasilewska Ewa
Paczkowska Edyta
Niesiobędzka-Krężel Joanna
Giannopoulos Krzysztof
Mahon Francois-Xavier
Sacha Tomasz
Saußele Susanne
Pfirrmann Markus
Volume
38
Issue
2
Pages
318-325
ISSN
0887-6924
eISSN
1476-5551
Access date
2024-01-02
Remarks
Online First 2023-12-21
Language
English
Container language
English
Views
4
WoS citations
1
cris.lastimport.scopus | 2024-04-07T17:55:38Z | |
cris.lastimport.wos | 2024-04-10T00:34:44Z | |
dc.cm.date | 2024-01-02T23:17:25Z | |
dc.cm.id | 114094 | pl |
dc.cm.idOmega | UJCM80560a16ecb249c196a1cde6d3aea541 | pl |
dc.contributor.author | Machova Polakova, Katerina | |
dc.contributor.author | Albeer, Ali | |
dc.contributor.author | Polivkova, Vaclava | |
dc.contributor.author | Krutska, Monika | |
dc.contributor.author | Vlcanova, Katerina | |
dc.contributor.author | Curik, Nikola | |
dc.contributor.author | Fabarius, Alice | |
dc.contributor.author | Klamova, Hana | |
dc.contributor.author | Spiess, Birgit | |
dc.contributor.author | Waller, Cornelius F. | |
dc.contributor.author | Brümmendorf, Tim H. | |
dc.contributor.author | Dengler, Jolanta | |
dc.contributor.author | Kunzmann, Volker | |
dc.contributor.author | Burchert, Andreas | |
dc.contributor.author | Belohlavkova, Petra | |
dc.contributor.author | Mustjoki, Satu | |
dc.contributor.author | Faber, Edgar | |
dc.contributor.author | Mayer, Jiri | |
dc.contributor.author | Zackova, Daniela | |
dc.contributor.author | Panayiotidis, Panayiotis | |
dc.contributor.author | Richter, Johan | |
dc.contributor.author | Hjorth-Hansen, Henrik | |
dc.contributor.author | Kamińska, Magdalena - 259130 | |
dc.contributor.author | Płonka-Stępień, Magdalena - 246438 | |
dc.contributor.author | Szczepanek, Elżbieta - 231097 | |
dc.contributor.author | Szarejko, Monika | |
dc.contributor.author | Bober, Grażyna | |
dc.contributor.author | Hus, Iwona | |
dc.contributor.author | Grzybowska-Izydorczyk, Olga | |
dc.contributor.author | Wasilewska, Ewa | |
dc.contributor.author | Paczkowska, Edyta | |
dc.contributor.author | Niesiobędzka-Krężel, Joanna | |
dc.contributor.author | Giannopoulos, Krzysztof | |
dc.contributor.author | Mahon, Francois-Xavier | |
dc.contributor.author | Sacha, Tomasz - 133344 | |
dc.contributor.author | Saußele, Susanne | |
dc.contributor.author | Pfirrmann, Markus | |
dc.date.accession | 2024-01-02 | pl |
dc.date.accessioned | 2024-01-02T23:17:25Z | |
dc.date.available | 2024-01-02T23:17:25Z | |
dc.date.issued | 2023 | pl |
dc.date.openaccess | 0 | |
dc.description.accesstime | w momencie opublikowania | |
dc.description.additional | Online First 2023-12-21 | pl |
dc.description.number | 2 | pl |
dc.description.physical | 318-325 | pl |
dc.description.version | ostateczna wersja wydawcy | |
dc.description.volume | 38 | pl |
dc.identifier.doi | 10.1038/s41375-023-02109-2 | pl |
dc.identifier.eissn | 1476-5551 | pl |
dc.identifier.issn | 0887-6924 | pl |
dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/324955 | |
dc.identifier.weblink | https://www.nature.com/articles/s41375-023-02109-2 | pl |
dc.language | eng | pl |
dc.language.container | eng | pl |
dc.rights | Dodaję tylko opis bibliograficzny | * |
dc.rights.licence | CC-BY | |
dc.rights.uri | * | |
dc.share.type | Otwarte czasopismo | |
dc.subtype | Article | pl |
dc.title | The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib | pl |
dc.title.journal | Leukemia | pl |
dc.type | JournalArticle | pl |
dspace.entity.type | Publication |
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
4
Views per month
Views per city
Krakow
4
No access
No Thumbnail Available